The Business Research Company’s report on the Mucosal Atomization Devices Market provides insights into the global market size, growth rate, regional distribution, competitive landscape, key segments, emerging trends, and strategic opportunities.
What are the primary drivers fueling the growth of the mucosal atomization devices market in recent years?
The increase in prevalence of allergic rhinitis across the world propels the growth of the mucosal atomization devices market. Allergic rhinitis refers to a range of symptoms that affect the nose and are brought by breathing allergens such as pollen, dust, or animal dander. Mucosal atomization devices are used to provide budesonide as a topical nasal steroid spray in chronic rhinosinusitis treatment. According to the Allergy Capital Report 2022, one of the most common allergic conditions is seasonal allergic rhinitis, often called hay fever. About 7.7% of adults and 7.2% of children have been diagnosed with seasonal allergic rhinitis in the United States. Therefore, the increasing prevalence of allergic rhinitis across the world drives the growth of the mucosal atomization devices market.
Access Your Free Sample of the Global Mucosal Atomization Devices Market Report – Get Insights Now!
Mucosal Atomization Devices Market Report 2025, Trends, Insights Sample
What is the projected market size of the mucosal atomization devices industry, and how is it expected to grow?
The mucosal atomization devices market size has grown strongly in recent years. It will grow from $0.85 billion in 2024 to $0.92 billion in 2025 at a compound annual growth rate (CAGR) of 9.1%. The growth in the historic period can be attributed to emergency medicine, anesthesia, pediatric care, pain management, dental procedures.
The mucosal atomization devices market size is expected to see rapid growth in the next few years. It will grow to $1.4 billion in 2029 at a compound annual growth rate (CAGR) of 10.9%. The growth in the forecast period can be attributed to chronic diseases, telemedicine, precision medicine, cosmetic procedures, patient comfort, autonomous vehicles. Major trends in the forecast period include sustainable and eco-friendly practices, digital mortuary management, green burial options, remote viewing and streaming services, hybrid funeral services.
Gain Exclusive Market Insights—Customize Your Research Report Today For Fast Delivery!
Mucosal Atomization Devices Market Report 2025, Trends, Insights Customise
Who are the key players driving competition in the mucosal atomization devices market?
Major companies operating in the mucosal atomization devices market include Teleflex Incorporated, DeVilbiss Healthcare LLC, Becton Dickinson and Company, Cook Medical LLC, Medica Holdings LLC, Life-Assist Inc., Pulmodyne Inc., Alcove Manufacturing and Distribution Inc., LMA North America Inc., Medline Industries Inc., Medtronic plc, Smiths Medical Inc., Vyaire Medical Inc., Westmed Inc., Mercury Medical, SunMed LLC, Salter Labs, Armstrong Medical Industries Inc., VBM Medizintechnik GmbH, Intersurgical Ltd., Flexicare Medical Limited, Medovations Inc., Medisize BV, Atom Medical Corporation, BLS Systems Limited, Central Admixture Pharmacy Services Inc., Dali Medical Devices Co. Ltd., Dynarex Corporation
What key trends are expected to drive the mortuary equipment market during the forecast period?
Major companies operating in the mortuary equipment market are adopting a strategic partnership approach to develop nasal powder delivery device technology. Strategic partnerships refer to a process in which companies leverage each other’s strengths and resources to achieve mutual benefits and success. For instance, in November 2023, Hovione, a Portugal-based provider of services for the development and manufacturing of pharmaceutical drugs, partnered with Industrial Design Consultancy (IDC), a UK-based product design and development company. The partnership aims to create an innovative nasal powder delivery device technology that facilitates local, systemic, and nose-to-brain drug delivery. These devices are designed to offer broad and targeted nasal deposition flexibility, ensuring maximum usability and reliability.
Which key geographies are driving the growth of the mucosal atomization devices market?
North America was the largest region in the mucosal atomization devices market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the mucosal atomization devices market report include Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
Order Your Report Now For Swift Delivery
Mucosal Atomization Devices Market Report 2025, Trends, Insights
What are the key segments driving growth in the mucosal atomization devices market?
The mucosal atomization devices market covered in this report is segmented –
1) By Type: Nasal Atomization Devices, Fiber-Optic Atomization Devices, Laryngo-Tracheal Atomization Devices, Bottle Atomizer Devices
2) By Technology: Gas Propelled Atomization Devices, Electrical Atomization Devices
3) By End User: Hospitals, Ambulatory Surgical Centers, Specialized Clinics
Subsegments:
1) By Nasal Atomization Devices: Handheld Nasal Sprays, Mechanical Nasal Atomizers, Electric Nasal Atomizers
2) By Fiber-Optic Atomization Devices: Portable Fiber-Optic Atomizers, Fixed Fiber-Optic Atomizers, Single-Use Fiber-Optic Atomizers
3) By Laryngo-Tracheal Atomization Devices: Jet Nebulizers, Ultrasonic Nebulizers, Portable Laryngo-Tracheal Atomizers
4) By Bottle Atomizer Devices: Manual Bottle Atomizers, Pressurized Bottle Atomizers, Plastic Bottle Atomizers
Purchase The Exclusive Report Now To Unlock Valuable Market Insights:
Mucosal Atomization Devices Market Report 2025, Trends, Insights
What defines the structure and scope of the mucosal atomization devices market?
Mucosal atomization devices offer medication through the nostrils. It is known for providing dependable topical solution atomization across the nasal and oropharyngeal mucous membranes. The mucosal atomization devices are used to deliver atomized medication to the mucosal surfaces of the nasal, oral, and larynx, trachea, and lungs.
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.
Our flagship product, the Global Market Model, is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: [email protected]
Follow Us On:
LinkedIn: The Business Research Company | LinkedIn
